Align Technology Inc (ALGN) — 分析摘要
Align Technology Inc(ALGN)的市值为12.93十亿美元,最近一年的营收同比增长了+0.9%。净利润率为10.2%。当前市盈率为30.1倍。
核心要点
- 营收同比变化+0.9%
- 净利润率10.2%
- 市盈率30.1倍
与ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES板块的其他公司相比,ALGN的营收增长为+0.9%,市盈率为30.1倍。
Align Technology Inc (ALGN)
更新 — ET · 来源 POLYGON
红旗与风险提示无重大红旗
基于最新财报,没有触发重大的信用、利润率或趋势红旗。
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
行业
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
员工人数
20,275
总部
TEMPE, AZ
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。